 | • レポートコード：B-GIR08C2061 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エロツズマブの世界市場について調べ、まとめました。種類別セグメントは、300mg注射剤、400mg注射剤等、用途別セグメントは、病院、診断検査室、その他等に区分しました。エロツズマブの世界市場概観、企業動向、企業別エロツズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エロツズマブの市場概観 ・エロツズマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エロツズマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・エロツズマブの世界市場規模 ・エロツズマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・エロツズマブのアメリカ市場規模推移 ・エロツズマブのカナダ市場規模推移 ・エロツズマブのメキシコ市場規模推移 ・エロツズマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エロツズマブのドイツ市場規模推移 ・エロツズマブのイギリス市場規模推移 ・エロツズマブのロシア市場規模推移 ・エロツズマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エロツズマブの日本市場規模推移 ・エロツズマブの中国市場規模推移 ・エロツズマブの韓国市場規模推移 ・エロツズマブのインド市場規模推移 ・エロツズマブの東南アジア市場規模推移 ・エロツズマブの南米市場分析（ブラジル、アルゼンチン等） ・エロツズマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エロツズマブの種類別分析/販売量、売上、市場シェア（300mg注射剤、400mg注射剤） ・エロツズマブの用途別分析/市場規模（病院、診断検査室、その他） ・エロツズマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エロツズマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Elotuzumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Elotuzumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bristol Myers Squibb
Abbvie
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
300mg Injection
400mg Injection
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Elotuzumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Elotuzumab, with price, sales, revenue and global market share of Elotuzumab in 2017 and 2018.
Chapter 3, the Elotuzumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Elotuzumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Elotuzumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Elotuzumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Elotuzumab Introduction
1.2 Market Analysis by Type
1.2.1 300mg Injection
1.2.2 400mg Injection
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol Myers Squibb
2.1.1 Business Overview
2.1.2 Elotuzumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol Myers Squibb Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Abbvie
2.2.1 Business Overview
2.2.2 Elotuzumab Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbvie Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Elotuzumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Elotuzumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Elotuzumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Elotuzumab Manufacturer Market Share in 2018
3.3.2 Top 6 Elotuzumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Elotuzumab Market Analysis by Regions
4.1 Global Elotuzumab Sales, Revenue and Market Share by Regions
4.1.1 Global Elotuzumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Elotuzumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Elotuzumab Sales and Growth Rate (2014-2019)
4.3 Europe Elotuzumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Elotuzumab Sales and Growth Rate (2014-2019)
4.5 South America Elotuzumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Elotuzumab Sales and Growth Rate (2014-2019)
5 North America Elotuzumab by Country
5.1 North America Elotuzumab Sales, Revenue and Market Share by Country
5.1.1 North America Elotuzumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Elotuzumab Revenue and Market Share by Country (2014-2019)
5.2 United States Elotuzumab Sales and Growth Rate (2014-2019)
5.3 Canada Elotuzumab Sales and Growth Rate (2014-2019)
5.4 Mexico Elotuzumab Sales and Growth Rate (2014-2019)
6 Europe Elotuzumab by Country
6.1 Europe Elotuzumab Sales, Revenue and Market Share by Country
6.1.1 Europe Elotuzumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Elotuzumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Elotuzumab Sales and Growth Rate (2014-2019)
6.3 UK Elotuzumab Sales and Growth Rate (2014-2019)
6.4 France Elotuzumab Sales and Growth Rate (2014-2019)
6.5 Russia Elotuzumab Sales and Growth Rate (2014-2019)
6.6 Italy Elotuzumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Elotuzumab by Country
7.1 Asia-Pacific Elotuzumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Elotuzumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Elotuzumab Revenue and Market Share by Country (2014-2019)
7.2 China Elotuzumab Sales and Growth Rate (2014-2019)
7.3 Japan Elotuzumab Sales and Growth Rate (2014-2019)
7.4 Korea Elotuzumab Sales and Growth Rate (2014-2019)
7.5 India Elotuzumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Elotuzumab Sales and Growth Rate (2014-2019)
8 South America Elotuzumab by Country
8.1 South America Elotuzumab Sales, Revenue and Market Share by Country
8.1.1 South America Elotuzumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Elotuzumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Elotuzumab Sales and Growth Rate (2014-2019)
8.3 Argentina Elotuzumab Sales and Growth Rate (2014-2019)
8.4 Colombia Elotuzumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Elotuzumab by Countries
9.1 Middle East and Africa Elotuzumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Elotuzumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Elotuzumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Elotuzumab Sales and Growth Rate (2014-2019)
9.3 Turkey Elotuzumab Sales and Growth Rate (2014-2019)
9.4 Egypt Elotuzumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Elotuzumab Sales and Growth Rate (2014-2019)
9.6 South Africa Elotuzumab Sales and Growth Rate (2014-2019)
10 Global Elotuzumab Market Segment by Type
10.1 Global Elotuzumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Elotuzumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Elotuzumab Revenue and Market Share by Type (2014-2019)
10.2 300mg Injection Sales Growth and Price
10.2.1 Global 300mg Injection Sales Growth (2014-2019)
10.2.2 Global 300mg Injection Price (2014-2019)
10.3 400mg Injection Sales Growth and Price
10.3.1 Global 400mg Injection Sales Growth (2014-2019)
10.3.2 Global 400mg Injection Price (2014-2019)
11 Global Elotuzumab Market Segment by Application
11.1 Global Elotuzumab Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Elotuzumab Market Forecast (2019-2024)
12.1 Global Elotuzumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Elotuzumab Market Forecast by Regions (2019-2024)
12.2.1 North America Elotuzumab Market Forecast (2019-2024)
12.2.2 Europe Elotuzumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Elotuzumab Market Forecast (2019-2024)
12.2.4 South America Elotuzumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Elotuzumab Market Forecast (2019-2024)
12.3 Elotuzumab Market Forecast by Type (2019-2024)
12.3.1 Global Elotuzumab Sales Forecast by Type (2019-2024)
12.3.2 Global Elotuzumab Market Share Forecast by Type (2019-2024)
12.4 Elotuzumab Market Forecast by Application (2019-2024)
12.4.1 Global Elotuzumab Sales Forecast by Application (2019-2024)
12.4.2 Global Elotuzumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Elotuzumab Picture
Table Product Specifications of Elotuzumab
Figure Global Sales Market Share of Elotuzumab by Types in 2018
Table Elotuzumab Types for Major Manufacturers
Figure 300mg Injection Picture
Figure 400mg Injection Picture
Figure Elotuzumab Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Elotuzumab Revenue (Value) and Growth Rate (2014-2024)
Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Elotuzumab Type and Applications
Table Bristol Myers Squibb Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Elotuzumab Type and Applications
Table Abbvie Elotuzumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Elotuzumab Sales by Manufacturer (2017-2018)
Figure Global Elotuzumab Sales Market Share by Manufacturer in 2017
Figure Global Elotuzumab Sales Market Share by Manufacturer in 2018
Table Global Elotuzumab Revenue by Manufacturer (2017-2018)
Figure Global Elotuzumab Revenue Market Share by Manufacturer in 2017
Figure Global Elotuzumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Elotuzumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Elotuzumab Manufacturer (Revenue) Market Share in 2018
Figure Global Elotuzumab Sales and Growth Rate (2014-2019)
Figure Global Elotuzumab Revenue and Growth Rate (2014-2019)
Table Global Elotuzumab Sales by Regions (2014-2019)
Table Global Elotuzumab Sales Market Share by Regions (2014-2019)
Table Global Elotuzumab Revenue by Regions (2014-2019)
Figure Global Elotuzumab Revenue Market Share by Regions (2014-2019)
Figure Global Elotuzumab Revenue Market Share by Regions in 2018
Figure North America Elotuzumab Sales and Growth Rate (2014-2019)
Figure Europe Elotuzumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Elotuzumab Sales and Growth Rate (2014-2019)
Figure South America Elotuzumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Elotuzumab Sales and Growth Rate (2014-2019)
Figure North America Elotuzumab Revenue and Growth Rate (2014-2019)
Table North America Elotuzumab Sales by Countries (2014-2019)
Table North America Elotuzumab Sales Market Share by Countries (2014-2019)
Figure North America Elotuzumab Sales Market Share by Countries (2014-2019)
Figure North America Elotuzumab Sales Market Share by Countries in 2018
Table North America Elotuzumab Revenue by Countries (2014-2019)
Table North America Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure North America Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure North America Elotuzumab Revenue Market Share by Countries in 2018
Figure United States Elotuzumab Sales and Growth Rate (2014-2019)
Figure Canada Elotuzumab Sales and Growth Rate (2014-2019)
Figure Mexico Elotuzumab Sales and Growth Rate (2014-2019)
Figure Europe Elotuzumab Revenue and Growth Rate (2014-2019)
Table Europe Elotuzumab Sales by Countries (2014-2019)
Table Europe Elotuzumab Sales Market Share by Countries (2014-2019)
Table Europe Elotuzumab Revenue by Countries (2014-2019)
Figure Europe Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure Europe Elotuzumab Revenue Market Share by Countries in 2018
Figure Germany Elotuzumab Sales and Growth Rate (2014-2019)
Figure UK Elotuzumab Sales and Growth Rate (2014-2019)
Figure France Elotuzumab Sales and Growth Rate (2014-2019)
Figure Russia Elotuzumab Sales and Growth Rate (2014-2019)
Figure Italy Elotuzumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Elotuzumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Elotuzumab Sales by Countries (2014-2019)
Table Asia-Pacific Elotuzumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Elotuzumab Sales Market Share by Countries 2018
Table Asia-Pacific Elotuzumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Elotuzumab Revenue Market Share by Countries 2018
Figure China Elotuzumab Sales and Growth Rate (2014-2019)
Figure Japan Elotuzumab Sales and Growth Rate (2014-2019)
Figure Korea Elotuzumab Sales and Growth Rate (2014-2019)
Figure India Elotuzumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Elotuzumab Sales and Growth Rate (2014-2019)
Figure South America Elotuzumab Revenue and Growth Rate (2014-2019)
Table South America Elotuzumab Sales by Countries (2014-2019)
Table South America Elotuzumab Sales Market Share by Countries (2014-2019)
Figure South America Elotuzumab Sales Market Share by Countries in 2018
Table South America Elotuzumab Revenue by Countries (2014-2019)
Table South America Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure South America Elotuzumab Revenue Market Share by Countries in 2018
Figure Brazil Elotuzumab Sales and Growth Rate (2014-2019)
Figure Argentina Elotuzumab Sales and Growth Rate (2014-2019)
Figure Colombia Elotuzumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Elotuzumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Elotuzumab Sales by Countries (2014-2019)
Table Middle East and Africa Elotuzumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Elotuzumab Sales Market Share by Countries in 2018
Table Middle East and Africa Elotuzumab Revenue by Countries (2014-2019)
Table Middle East and Africa Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elotuzumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Elotuzumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Elotuzumab Sales and Growth Rate (2014-2019)
Figure UAE Elotuzumab Sales and Growth Rate (2014-2019)
Figure Egypt Elotuzumab Sales and Growth Rate (2014-2019)
Figure Nigeria Elotuzumab Sales and Growth Rate (2014-2019)
Figure South Africa Elotuzumab Sales and Growth Rate (2014-2019)
Table Global Elotuzumab Sales by Type (2014-2019)
Table Global Elotuzumab Sales Share by Type (2014-2019)
Table Global Elotuzumab Revenue by Type (2014-2019)
Table Global Elotuzumab Revenue Share by Type (2014-2019)
Figure Global 300mg Injection Sales Growth (2014-2019)
Figure Global 300mg Injection Price (2014-2019)
Figure Global 400mg Injection Sales Growth (2014-2019)
Figure Global 400mg Injection Price (2014-2019)
Table Global Elotuzumab Sales by Application (2014-2019)
Table Global Elotuzumab Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Elotuzumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Elotuzumab Sales Forecast by Regions (2019-2024)
Table Global Elotuzumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Elotuzumab Market Forecast (2019-2024)
Figure Europe Sales Elotuzumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Elotuzumab Market Forecast (2019-2024)
Figure South America Sales Elotuzumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Elotuzumab Market Forecast (2019-2024)
Table Global Elotuzumab Sales Forecast by Type (2019-2024)
Table Global Elotuzumab Market Share Forecast by Type (2019-2024)
Table Global Elotuzumab Sales Forecast by Application (2019-2024)
Table Global Elotuzumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ベリムマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Belimumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Belimumab in global market, e…- シルツキシマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Siltuximab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Siltuximab in global market,…
- 薬物注入装置の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Drug Injection Devices is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Drug Injection Devices in …
- スルファジアジンナトリウム注射の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Sulfadiazine Sodium Injection is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Sulfadiazine Sodium…
- 薬物注入装置市場：世界及び中国の市場分析・予測（～2024年） Drug Injection Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drug Injection Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Injection Devices m…